Need a perfect paper? Place your first order and save 5% with this code:   SAVE5NOW

Ethical Challenges in the Use of Genetically Modified Organisms (GMOs) in Agriculture

Benefits of GMO

About 17.2% of the world’s population has access to adequate and nutritious food, underscoring the urgency of the issue (Ghimire et al. 1). Current global crop yield growth is less than 1.7%, lower than 2.4% a needed to meet the growing demand for cereals and to improve nutritional quality Availability (Ghimire et al. 1). The Food and Agriculture Organization (FAO) predicts that arable land on which crops may be grown will lower from 0.242 ha to 0.18 ha through 2050 (Ghimire et al. 1). It takes into account constraints such as seasonality (Ghimire et al. 1). Looking beforehand, the looming risk of non-stop international warming, specifically in regions experiencing water shortages, should have adverse outcomes on plants. To cope with those demanding situations, the creation of modified genes, including Sh2 and Bt2, affords a promising approach to assist vegetation facing high temperatures (Karalis et al. 3). Adopting innovative strategies and technologies is crucial for making sure sustainable and resilient agriculture inside the face of evolving international conditions.

Advanced biotechnology has led to the development of genetically modified plants and products that hold promise to alleviate global food shortages and improve nutrient availability (Ghimire et al. 2). This innovative approach can give plants desired traits in less time, reducing gene interaction issues in elite cultivars The benefits extend beyond trait enhancement, with improved nutrient levels per million plants 20 species of the same genus are included, making it a valuable source of tasty and nutritious food (Ghimire et al. 2). Genetic engineering techniques have expanded the gene pool in plant species, breaking down natural barriers and speeding up the creation of new varieties. These techniques have found tremendous utility in agriculture, facilitating strategies such as in vitro cell and DNA propagation by tissue culture. In addition, they play a critical position in developing transgenic plant life for drug screening, biosynthesis of active compounds, enzymes, hormones, blood substitutes, vaccines, antibodies, and various commercial merchandise (Ghimire et al. 2).

Detailed and long-term research verifies the extensive blessings of genetically modified crops in reducing worldwide food insecurity and starvation (Karlis et al. 2). As the global population continues to grow, attention has shifted to the benefits of GMOs, emphasizing their potential for poverty alleviation Notably, GMO crops such as soybean, cotton have been approved, tomatoes, potatoes, canola and maize on for commercial use, and have taken a step forward in the adoption of this technology Marked (Ghimire et al. 2). The potential of genetically modified organisms (GMOs) extends well beyond poverty alleviation, including contributing to the overall sustainability of agriculture and improving nutritional and medical standards. Through intention based on the positive results of genetic research, researchers aim to harness its full potential to benefit the global population.

Opposing Views

Although GMOs offer advantages, concerns about their biosafety have caused considerable concern, particularly research on human health, environmental plausibility, and regulatory issues (Karlis et al. 1). Karlis et al. show a fundamental interaction between genetically modified plants and their environment (1). This interaction raises fears about the possibility of transferring introduced genes to plants or other organisms in the ecosystem. Gene transfer by pollen can cause genetic contamination, especially between interacting plant species. The consequences of genetic infection are noteworthy, with wild herb varieties going through an aggressive disadvantage towards genetically changed crops. This could bring about the decline or disappearance of wild types, changing international biodiversity. The shift in biodiversity might also cause improved resistance among sure weed species, the dominance of others, and the decline or disappearance of some, inflicting a massive and disruptive deregulation in ecosystems (Karalis et al. 1). In clinical circles, there is a consensus that ongoing studies are vital to as it should be and comprehensively verify the dangers and advantages associated with genetically changed crops.

The consequences of genetic diseases are noteworthy, and wild herbaceous plants suffer heavy losses in genetically modified crops. This seeks to alter international biodiversity and wild plants declining or extinct species have occurred. Changing ecosystems can lead to increased resistance to some weed species, dominance of others, decline or even extinction of some, leading to severe and disruptive ecological regulation (Karlis et al. 1)

Furthermore, introducing a gene expressing a non-allergenic protein in GM plants does not guarantee the absence of allergenic properties in the final product. Researchers express skepticism about the intensified and potentially hazardous nature of allergies from GM products, as these foods exhibit a more substantial allergenic potential than conventional plants. Although antibiotic-resistant genes have diminished in most modified products, a new difficulty arises with the full-size software of antibiotics in animal feed. This practice ends in the presence of antibiotics in dairy merchandise and meat consumed by humans, contributing to the improvement of antibiotic-resistant germs in the human digestive gadget (Karalis et al. 2). Despite these demanding situations, further research and research are vital to determine the differences among transgenic and conventional plants and to ascertain whether GM plants pose additional risks to the consumer public.

Plan to Promote GMO Use in Agriculture

It is vital to address potential concerns to strengthen the case for GMOs. According to the precautionary principle, new genetically modified products should not reach customers without solid evidence of their safety or if there are conflicting evaluations among researchers (Karalis et al. 3). Recent research highlights that advancements like CRISPR in genetic engineering offer more precise modifications with fewer unintended effects. The CRISPR process, which avoids introducing foreign DNA into plant genomes, classifies many plant products as non-GMO among scientists. Consequently, some items developed through this technology may not require GMO labeling under USDA rules (Meyer and Dastgheib-Vinarov 16). These factors collectively ensure that intentionally released genetically modified organisms pose no harm to people or the environment, addressing concerns and fostering a safer perception of GMOs.

A significant worry arises regarding the potential spread of genes from genetically modified (GM) plants to other organisms in the environment, risking genetic contamination and the transmission of allergenic traits. Lu shows that a sensible approach to minimizing the switch of genes is imposing bodily isolation between GM pollen donors and recipients (111). This entails growing a separate area, such as open land or fields with non-GM plant species, appearing as a barrier to pollen going with the flow (Lu 111). Another method is allowing farmers to declare their location as both a GM crop-loose area or a GM crop manufacturing quarter through voluntary agreements, potentially supported by using governments (Lu 112). With its lower costs, this strategy could be the most effective means to ensure the confined presence of GM crops and encourage coexistence on a regional scale, addressing concerns about gene flow in a creative and professional manner.

Genetically modified products incorporating antibiotic-resistant genes have sparked valid worries about human antibiotic resistance. A promising solution lies in CRISPR-Cas system-mediated removal of these genes (Wu 9). This centered method gives a capacity device for clinically coping with transmitting drug-resistance genes and drug-resistant pathogens. Turnbull et al. emphasize that ensuring food safety, animal feed, and the environment is crucial in assessing the risks associated with agricultural technology. These standards apply universally to all agricultural products, including those developed through traditional plant breeding methods. The regulations aim to address potential negative impacts of genetically modified organisms (GMOs) to safeguard human health and the environment during environmental releases, making GM products available for public use. These regulatory frameworks are being implemented in anticipation of the commercialization of GMOs, underscoring the commitment to responsible and safe agriculture.

Anticipation of and answer to possible counterarguments.

Opponents say that even with gene specificity, the future impact of GMOs is still being determined. In the latter case, it is essential to emphasize a commitment to practical testing, monitoring, and regulatory reform. This ensures that we can better manage potential risks as our knowledge increases. Another opposing argument questions whether smallholder farmers can reap the benefits of advanced genetic technologies. Enhancement of GMO approval programs should integrate technology transfer, capacity building, and community engagement.

Works Cited

Ghimire, Bimal Kumar, et al. “Assessment of Benefits and Risk of Genetically Modified Plants and Products: Current Controversies and Perspective.” Sustainability 15.2 (2023): 1722.

Karalis, Dimitrios T., et al. “Genetically modified products, perspectives and challenges.” Cureus 12.3 (2020).

Lu, Bao-Rong. “Transgene escape from GM crops and potential biosafety consequences: an environmental perspective.” Collection of Biosafety reviews 4 (2008): 66-141.

Meyer, Abby, and Sara Dastgheib-Vinarov. “The Future of Food? CRISPR-Edited Agriculture.” FDLI Update (2021): 14.

Turnbull, Crystal, Morten Lillemo, and Trine AK Hvoslef-Eide. “Global regulation of genetically modified crops amid the gene edited crop boom–a review.” Frontiers in Plant Science 12 (2021): 630396.

Wu, Yuye, et al. “Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections.” Journal of nanobiotechnology 19.1 (2021): 1-26.

 

Don't have time to write this essay on your own?
Use our essay writing service and save your time. We guarantee high quality, on-time delivery and 100% confidentiality. All our papers are written from scratch according to your instructions and are plagiarism free.
Place an order

Cite This Work

To export a reference to this article please select a referencing style below:

APA
MLA
Harvard
Vancouver
Chicago
ASA
IEEE
AMA
Copy to clipboard
Copy to clipboard
Copy to clipboard
Copy to clipboard
Copy to clipboard
Copy to clipboard
Copy to clipboard
Copy to clipboard
Need a plagiarism free essay written by an educator?
Order it today

Popular Essay Topics